AVEO Oncology

AVEO Oncology, an?LG Chem?company, attended the?#JADPROLive? Conference in Dallas, TX, this past week. Our team had the opportunity to meet with Advanced Practitioners and industry peers from across the country. Thank you for visiting us and we look forward to seeing you all in 2025!

Beware of false recruitment offers! ? We have recently become aware of attempts by individuals falsely representing that they are associated with the HR Department at AVEO Oncology to solicit personal information and funds through various recruiting websites. People behind this activity have been using e-mail addresses with “AVEO” in the username or the domain name and have been arranging fake job interviews through messaging platforms.?Please be advised that these individuals do not represent AVEO Oncology and are in no way part of the AVEO Oncology organization or otherwise associated with AVEO Oncology. ? We urge job applicants to carefully check and confirm the credentials of any person or organization that represents itself as being associated with AVEO Oncology before responding to any advertisements or e-mail solicitations. ? We further urge job applicants to critically assess requests made by any such recruiters. Unusual requests for personal information and/or credentials, for example passport or banking information, or offers to send checks to job applicants in return for wire payments may be a sign that such recruiters are not engaged in a legitimate business activity. ? AVEO Oncology career opportunities are currently advertised on [https://lnkd.in/eM_KQnmq]. Job seekers can view and apply for openings with AVEO Oncology directly on our website: www.aveooncology.com .

On this Veterans Day,?AVEO Oncology, an?LG Chem?company, would like to express our gratitude for those who have proudly served or are currently serving our country.?We thank you for defending our freedom each day of the year. #veteransday2024 #militaryservice

AVEO Oncology, an LG Chem company, is proud to sponsor the Kidney Cancer Association 2024 International Kidney Cancer Symposium: North America, November 7-9, 2024, in Louisville, KY. We look forward to joining oncology experts and industry partners to discuss the latest science and research in the kidney cancer community. #IKCS24 #oncology #pharma #biotech #kidneycancer

Congratulations to our colleague and friend,?AVEO Oncology, an?LG Chem company,?Senior Manager of Administrative Services?Holly Evers, who was nominated for this year’s 6th?Annual?The Admin Awards?#SpiritAward? (Boston & New England Region).?The Spirit Award celebrates the extraordinary contributions of administrative professionals across various industries.?Both Holly and team member?Logan Byrnes?have wholeheartedly enriched the culture at AVEO with their enthusiasm and dedication to our employees. Please join us in congratulating and celebrating both Holly and Logan for all that they do! https://lnkd.in/gBJ5PZr ? #adminawards2024 #BostonCompanies #administrativeassistant #employeerecognition #oncology #pharma #biotech

AVEO Oncology, an?LG Chem?company, returned from an insightful?ESMO - European Society for Medical Oncology?2024 congress?in Barcelona, Spain. In addition to presenting the late breaking TiNivo-2 clinical study results and a TIVO-3 exploratory post immunotherapy survival analysis, the team met with industry experts who shared their insights on the latest research and data in the kidney cancer community.? ? #ESMO24 #TiNivo2 #oncology #pharma #biotech #kidneycancer

Each September 24th,?#WorldCancerResearchDay?calls attention to the importance of cancer research and advancing treatment strategies. This year’s?#WCRD?is primarily focused on “Innovation in Cancer Research” and how it can “Drive Progress Toward Health Equity." AVEO Oncology,?an?LG Chem?company, honors today with a parallel core company mission dedicated to providing innovative solutions to improve the lives of patients with cancer. #WCRD2024?#oncology?#biotech?#pharma

AVEO Oncology, an LG Chem company, announced that both the TiNivo-2 clinical study results as well as a TIVO-3 exploratory post immunotherapy survival analysis were presented this past weekend at the ESMO - European Society for Medical Oncology congress 2024 in Barcelona, Spain. In conjunction with the scientific presentation, the TiNivo-2 data were simultaneously published in the prestigious journal, The Lancet. For more information on both presentations and study results, you can read the full press release here: https://lnkd.in/e2FV8F4s #ESMO2024 #tinivo2

Today,?AVEO Oncology, an?LG Chem?company, remembers and honors those who tragically lost their lives on September 11th. #neverforget #911 #september11 #911anniversary

AVEO Oncology, an?LG Chem?company, announced their late-breaking abstract detailing their Phase 3 TiNivo-2 trial has been selected as a Proffered Paper oral presentation at the 2024?ESMO - European Society for Medical Oncology?congress in Barcelona, Spain, September 13th - 17th. The presentation will announce the results from the TiNivo-2 clinical trial, which was designed to evaluate the treatment of tivozanib in combination with nivolumab, versus tivozanib as a single agent therapy to investigate continued immunotherapy combination in a relapsed refractory setting. Learn more here:?https://lnkd.in/gpn2wEV4 ? #ESMO2024 #oncology #pharma #biotech